Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.6503
+0.0097 (1.51%)
Oct 19, 2026, 4:00 PM EDT - Market closed
RANI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.88 | 1.63 | 1.03 | - | - | 2.72 | |
Revenue Growth | 306.42% | 58.85% | - | - | - | 488.10% |
Gross Profit | 4.88 | 1.63 | 1.03 | - | - | 2.72 |
Selling, General & Admin | 19.53 | 19.74 | 23.95 | 26.48 | 26.84 | 27.83 |
Research & Development | 18.31 | 20.21 | 26.68 | 39.62 | 36.61 | 26.48 |
Operating Expenses | 37.84 | 39.94 | 50.63 | 66.1 | 63.45 | 54.32 |
Operating Income | -32.96 | -38.31 | -49.6 | -66.1 | -63.45 | -51.6 |
Interest Expense | -1.17 | -2.89 | -5.03 | -5.09 | -1.07 | -0.47 |
Interest & Investment Income | 1.28 | 0.83 | 1.76 | 3.3 | 1.25 | 0.09 |
Other Non Operating Income (Expenses) | - | - | - | - | - | -0.37 |
EBT Excluding Unusual Items | -32.85 | -40.37 | -52.87 | -67.88 | -63.27 | -52.35 |
Asset Writedown | - | - | -3.71 | - | - | - |
Other Unusual Items | -0.58 | -0.58 | - | - | - | -0.7 |
Pretax Income | -33.42 | -40.95 | -56.58 | -67.88 | -63.27 | -53.05 |
Income Tax Expense | - | - | - | - | 0.07 | 0.04 |
Earnings From Continuing Operations | -33.42 | -40.95 | -56.58 | -67.88 | -63.34 | -53.09 |
Minority Interest in Earnings | 3.28 | 11.28 | 26.57 | 33.91 | 32.76 | 44.76 |
Net Income | -30.14 | -29.67 | -30.02 | -33.97 | -30.59 | -8.33 |
Net Income to Common | -30.14 | -29.67 | -30.02 | -33.97 | -30.59 | -8.33 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 139 | 66 | 28 | 26 | 24 | 20 |
Shares Outstanding (Diluted) | 139 | 66 | 28 | 26 | 24 | 20 |
Shares Change | 321.63% | 132.26% | 11.65% | 7.09% | 21.93% | -58.34% |
EPS (Basic) | -0.22 | -0.45 | -1.05 | -1.33 | -1.28 | -0.43 |
EPS (Diluted) | -0.22 | -0.45 | -1.05 | -1.33 | -1.28 | -0.43 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -20.34 | -18.8 | -35.76 | -52.47 | -48.13 | -32.75 |
Free Cash Flow Per Share | -0.15 | -0.28 | -1.26 | -2.06 | -2.02 | -1.68 |
Gross Margin | 100.00% | 100.00% | 100.00% | - | - | 100.00% |
Operating Margin | -675.80% | -2345.99% | -4824.90% | - | - | -1899.12% |
Profit Margin | -618.02% | -1817.09% | -2920.04% | - | - | -306.63% |
Free Cash Flow Margin | -417.04% | -1151.38% | -3478.99% | - | - | -1205.41% |
EBITDA | -32.24 | -37.41 | -48.57 | -65.28 | -62.9 | -51.1 |
D&A For EBITDA | 0.72 | 0.9 | 1.03 | 0.82 | 0.55 | 0.5 |
EBIT | -32.96 | -38.31 | -49.6 | -66.1 | -63.45 | -51.6 |